The owners of an innovative digital company operating in the pharma industry decided to look for potential buyers of their company or venture investors able to invest money into a perspective project. The company has already been funded by an investor, however, for a full rollout of their product, they would need additional capital from investors.
This company for sale is a small company specialized in digital marketing in the healthcare and pharmaceutical industries. Currently, the company targets European markets and South America. The company is targeting mainly generic and original pharma companies.
The company’s customers include for example
The company is highly innovative and strives to bring digitalization into the pharma industry. The company wants to be the leader of this trend, and it already has helped many companies with digitalization.
The company has an experienced management team, with 60+ years of cumulative experience in the healthcare and pharmaceutical industries. This team would stay in the company also after the entry of the investor.
Contact us to get details about this digital pharma company for sale
The product of the company is a software solution - digital marketing tool with multiple functionalities. The product has been already implemented at several clients, with high customer satisfaction and success stories. The main future of the company’s product is the capability for healthcare intuitions market and communicate directly to professionals in the healthcare sector. The full functionality of the software will be disclosed to seriously interested parties upon an NDA.
The company is only in its startup phase, however, it has commercialized its product already and generated revenues. The project plan counts with a lucrative IRR for investors of over 75%.
For fast roll-out of the company’s product, the owners will need a capital injection of approx. 5-10 million EUR. After rolling out, the project will demonstrate exponential growth in revenues and profits. In 5 years, the cash flow plan is projecting revenues of over 70 million EUR and EBITDA at 50 million EUR.
Feel free to contact us for more information regarding this pharmaceutical digital company for sale. If this pharma company based in Europe for sale does not fit your requirements, feel free to ask for other pharma companies for sale . For buyers of pharma-related companies please visit the section pharma companies wanted.
Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.